Results 301 to 310 of about 1,015,424 (347)
Some of the next articles are maybe not open access.
International journal of clinical pharmacology and therapeutics, 2014
OBJECTIVES To assess the impact of sugammadex on activated partial thromboplastin time (APTT) and international normalized ratio for prothrombin time (PT(INR)) in healthy subjects and characterize the concentration-dependency of sugammadex effects on ...
P. De Kam+7 more
semanticscholar +1 more source
OBJECTIVES To assess the impact of sugammadex on activated partial thromboplastin time (APTT) and international normalized ratio for prothrombin time (PT(INR)) in healthy subjects and characterize the concentration-dependency of sugammadex effects on ...
P. De Kam+7 more
semanticscholar +1 more source
Thrombosis and Haemostasis, 2013
Summary Dabigatran is an oral direct thrombin inhibitor that does not require routine laboratory monitoring. However, an assessment of its anticoagulant effect in certain clinical settings is desirable.
G. Hapgood+4 more
semanticscholar +1 more source
Summary Dabigatran is an oral direct thrombin inhibitor that does not require routine laboratory monitoring. However, an assessment of its anticoagulant effect in certain clinical settings is desirable.
G. Hapgood+4 more
semanticscholar +1 more source
Shortened activated partial thromboplastin time: causes and management
Blood Coagulation & Fibrinolysis, 2010Throughout the long history of the hemostasis laboratory, and as an evaluation of the coagulation cascade, the results of the activated partial thromboplastin time (APTT) have primarily been considered as an index of loss-of-function and rarely as an index of gain-of-function.
LIPPI, Giuseppe+4 more
openaire +4 more sources
American Journal of Clinical Pathology, 1961
The partial thromboplastin time (PPT) test consists of recalcifying plasma in the presence of a lipid reagent that supplies optimal platelet thromboplastic factor-like activity.
Robert R. Proctor, S. Rapaport
semanticscholar +1 more source
The partial thromboplastin time (PPT) test consists of recalcifying plasma in the presence of a lipid reagent that supplies optimal platelet thromboplastic factor-like activity.
Robert R. Proctor, S. Rapaport
semanticscholar +1 more source
Extremely Shortened Activated Partial Thromboplastin Times
JAMA: The Journal of the American Medical Association, 1980To the Editor.— The presence of a hypercoagulable state in patients with a shortened activated partial thromboplastin time (APTT) as manifested by the clinical association with an increased incidence of thromboembolic disease has previously been reported by Hume, 1 Gallus et al, 2 Pilgeram, 3 McKenna et al, 4 and McKenna et al.
openaire +3 more sources
Correlation Between Activated Clotting Time and Activated Partial Thromboplastin Times
The Annals of Pharmacotherapy, 2002OBJECTIVE: To evaluate the correlation between clotting time tests and heparin concentration, the correlation between activated clotting time (ACT) and activated partial thromboplastin time (aPTT) results, and to compare the clinical decisions based on ACT results with those based on aPTT results.
Susan J. Westley+6 more
openaire +2 more sources
International Journal of Laboratory Hematology, 2013
We report the effect of temperature and storage duration on a range of haematological analytes: activated partial thromboplastin time (APTT), D‐dimers, fibrinogen (Fbg), prothrombin time (PT) and thrombin time (TT).
Y. Zhao, G. Lv
semanticscholar +1 more source
We report the effect of temperature and storage duration on a range of haematological analytes: activated partial thromboplastin time (APTT), D‐dimers, fibrinogen (Fbg), prothrombin time (PT) and thrombin time (TT).
Y. Zhao, G. Lv
semanticscholar +1 more source
Prothrombin Time and Partial Thromboplastin Time Assay Considerations
Clinics in Laboratory Medicine, 2009Prothrombin times and activated partial thromboplastin times have long been used as tests of overall ("global") clotting function. Laboratory coagulation testing issues should be at the forefront of the reader's consciousness whenever critically evaluating and extrapolating published study conclusions reliant on the results of these tests.
openaire +3 more sources
Coagulation Studies: Prothrombin Time, Partial Thromboplastin Time, Bleeding Time
Emergency Medicine Clinics of North America, 1986Three coagulation tests available in the emergency department are described in this article. Methods, results, and implications in the bleeding patient are reviewed.
Glenn C. Hamilton, Mark G. Angelos
openaire +3 more sources
Partial Thromboplastin Time Reagents: Another Look
Laboratory Medicine, 1985Ellagic acid and micronized silica, respectively, are the activating agents in two commonly used commercial partial thromboplastin time reagents. The two reagents were compared for their ability to detect partial deficiencies of clotting factors. The normal ranges for each were first determined using one semiautomated clot-detecting machine.
Lorraine Bauman, Theodore S. Zimmerman
openaire +2 more sources